What is HemOnc101?
HemOnc101 operates at the intersection of medical education and clinical support, providing a comprehensive suite of resources for both healthcare professionals and patients. By offering high-level board review lectures and specialized educational content, the company serves as a critical knowledge hub for hematology and oncology. Beyond its digital footprint, the organization maintains a focus on the South Miami community, facilitating advanced cancer care environments that prioritize patient empowerment and treatment literacy. Their model effectively democratizes access to complex medical information, covering a broad spectrum of malignancies including breast, lung, and prostate cancers.
How much funding has HemOnc101 raised?
HemOnc101 has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in HemOnc101
PPP
Public-Private Partnership
What's next for HemOnc101?
With this latest strategic investment, HemOnc101 is poised to expand its digital content library and enhance its clinical support services. The organization will likely focus on scaling its educational platform to reach a broader demographic of healthcare providers while simultaneously deepening its community-based care initiatives. By leveraging this capital, HemOnc101 aims to solidify its market position as a leading authority in oncological education, potentially integrating more advanced diagnostic support tools and expanding its reach into new geographic markets to address the growing demand for specialized cancer care resources.
See full HemOnc101 company page
